Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

After a difficult trading period, this company's sales and profits are set to expand rapidly in the coming years.

Most of the time, balance transfer fees are worth it. Here's how the math works, and the rare times when they don't make ...

Wednesday morning, Smurfit published its third-quarter numbers. These showed that the company's net sales were slightly over ...

One of the top holders of the iShares Bitcoin Trust is billionaire Israel "Izzy" Englander of Millennium Capital Management.

The company's squashed the consensus estimate for third-quarter profitability, and impressed investors and analysts alike.

International dividend stocks are finally having their moment after years of underperformance, and this single Vanguard fund ...

If the nuclear start-up can pull off a successful prototype, its options could be limitless. But that's a big "if." ...

One analyst felt compelled to downgrade the stock soon after it published quarterly earnings.

These words clearly indicate that Nvidia still has massive room for growth and remains a buy going into its quarterly report.

Will Netflix's 10-for-1 stock split help or hurt the stock? Here's what investors need to know before the headline-worthy ...

In the wake of strong quarterly results, analysts became notably more bullish on the company, and it heralded a new financing ...